Neurological Complications of Hematopoietic Cell Transplantation

 

 Buy Article Permissions and Reprints

ABSTRACT

Hematopoietic cell transplantation (HCT) involves the intravenous infusion of hematopoietic progenitor cells from the patient (autologous) or a human leukocyte antigen-matched donor (allogeneic). Before transplantation, the recipient undergoes a conditioning regimen with high-dose chemotherapy or radiotherapy (or both) to destroy a defective bone marrow or residual cancer cells. After allogenic HCT chronic immunosuppression is needed to prevent graft rejection and graft-versus-host disease. The frequency and type of neurological complication depends on the type of HCT, the underlying disease, and the case ascertainment. In this review the neurological complications are presented according to the stage of HCT that they are most likely to occur: (1) conditioning: drug-related encephalopathies and seizures or complications secondary to medical procedures; (2) bone marrow depletion: metabolic and drug-related encephalopathies and seizures, septic cerebral infarctions, and hemorrhages; (3) chronic immunosuppression: infections by viruses and opportunistic organisms; and (4) late events: central nervous system relapses of the original disease, neurological complications of graft versus host disease, and second neoplasms.

REFERENCES

• 1 Armitage J O. Bone marrow transplantation.  N Engl J Med. 1994;  330 827-838
  CrossrefPubMedGoogle Scholar
• 2 Davis D G, Patchell R A. Neurologic complications of bone marrow transplantation.  Neurol Clin. 1988;  6 377-387
  PubMedGoogle Scholar
• 3 Openshaw H, Slatkin E N. Neurological complications. In: Thomas ED, Blume KG, Forman SJ Hematopoietic Cell Transplantation Malden MA; Blackwell Scientific Inc 1999: 659-673
  Google Scholar
• 4 Patchell R A. Neurological complications of organ transplantation.  Ann Neurol. 1994;  36 688-703
  CrossrefPubMedGoogle Scholar
• 5 Wiznitzer M, Packer R J, August C S, Burkey E D. Neurological complications of bone marrow transplantation in childhood.  Ann Neurol. 1984;  16 569-576
  CrossrefPubMedGoogle Scholar
• 6 Patchell R A, White C L, Clark A W, Beschorner W E, Santos G W. Neurological complications of bone marrow transplantation.  Neurology. 1985;  35 300-306
  PubMedGoogle Scholar
• 7 Mohrmann R L, Mah V, Vinters H V. Neuropathologic findings after bone marrow transplantation: an autopsy study.  Hum Pathol. 1990;  21 630-639
  CrossrefPubMedGoogle Scholar
• 8 Graus F, Saiz A, Sierra J et al.. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: A comparative study.  Neurology. 1996;  46 1004-1009
  PubMedGoogle Scholar
• 9 Antonini G, Ceschin V, Morino S et al.. Early neurologic complications following allogeneic bone marrow transplant for leukemia.  Neurology. 1998;  50 1441-1445
  PubMedGoogle Scholar
• 10 Bleggi-Torres L F, de Medeiros B C, Werner B et al.. Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases.  Bone Marrow Transplant. 2000;  25 301-307
  CrossrefPubMedGoogle Scholar
• 11 de Brabander C, Cornelissen J, Smitt P A, Vecht C J, van den Bent M J. Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors.  J Neurol Neurosurg Psychiatry. 2000;  68 36-40
  CrossrefPubMedGoogle Scholar
• 12 Snider S, Bashir R, Bierman P. Neurologic complications after high-dose chemotherapy and autologous bone marrow transplantation for Hodgkin's disease.  Neurology. 1994;  44 681-684
  PubMedGoogle Scholar
• 13 Lieberman F, Gulati S. Headaches after inadvertent lumbar puncture during bone marrow harvest.  Neurology. 1996;  46 268-269
  PubMedGoogle Scholar
• 14 Sylvestre D L, Sandson T A, Nachmanoff D B. Transient brachial plexopathy as a complication of internal jugular vein cannulation.  Neurology. 1991;  41 760
  PubMedGoogle Scholar
• 15 DiMaggio J R, Brown R, Baile W F, Schapira D. Hallucinations and ifosfamide-induced neurotoxicity.  Cancer. 1994;  73 1509-1514
  CrossrefPubMedGoogle Scholar
• 16 Posner J B. Side effects of chemotherapy. In: Neurologic Complications of Cancer Philadelphia; FA Davis Company 1995: 282-310
  Google Scholar
• 17 Tahsildar H I, Remler B F, Creger R J et al.. Delayed, transient encephalopathy after marrow transplantation: case reports and MRI findings in four patients.  J Neurooncol. 1996;  27 241-250
  CrossrefPubMedGoogle Scholar
• 18 Hoyt R, Szer J, Grigg A. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells.  Bone Marrow Transplant. 2000;  25 1285-1287
  CrossrefPubMedGoogle Scholar
• 19 Dixit S, Kurle P, Buyan-Dent L, Sheth R D. Status epilepticus associated with cefepime.  Neurology. 2000;  54 2153-2155
  PubMedGoogle Scholar
• 20 Bleggi-Torres L F, Medeiros B C, Ogasawara V SA et al.. Iatrogenic Wernicke's encephalopathy in allogeneic bone marrow transplantation: a study of eight cases.  Bone Marrow Transplant. 1997;  20 391-395
  CrossrefPubMedGoogle Scholar
• 21 Wade J C, Meyers J D. Neurologic symptoms associated with parenteral acyclovir treatment after marrow transplantation.  Ann Intern Med. 1983;  98 921-925
  PubMedGoogle Scholar
• 22 Gordon B, Lyden E, Lynch J et al.. Central nervous system dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients.  Bone Marrow Transplant. 2000;  25 79-83
  CrossrefPubMedGoogle Scholar
• 23 Pomeranz S, Naparstek E, Ashkenazi E et al.. Intracranial hematomas following bone marrow transplantation.  J Neurol. 1994;  241 252-256
  CrossrefPubMedGoogle Scholar
• 24 Colosimo M, McCarthy N, Jayasinghe R, Morton J, Taylor K, Durrant S. Diagnosis and management of subdural hematoma complicating bone marrow transplantation.  Bone Marrow Transplant. 2000;  25 549-552
  CrossrefPubMedGoogle Scholar
• 25 Coplin W M, Cochran M S, Levine S R, Crawford S W. Stroke after bone marrow transplantation. Frequency, aetiology and outcome.  Brain. 2001;  124 1043-1051
  CrossrefPubMedGoogle Scholar
• 26 DeLone D R, Goldstein R A, Petermann G et al.. Disseminated aspergillosis involving the brain: distribution and imaging characteristics.  AJNR Am J Neuroradiol. 1999;  20 1597-1604
  PubMedGoogle Scholar
• 27 Jantunen E, Piilonen A, Volin L, Parkkali T, Koukila-Kahkola P, Ruutu T. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients.  Bone Marrow Transplant. 2000;  25 867-871
  CrossrefPubMedGoogle Scholar
• 28 Jantunen E, Ruutu P, Piilonen A, Volin L, Parkkali T, Ruutu T. Treatment and outcome of invasive aspergillus infections in allogeneic BMT recipients.  Bone Marrow Transplant. 2000;  26 759-762
  CrossrefPubMedGoogle Scholar
• 29 Patterson T F, Kirkpatrick W R, White M et al.. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes.  Medicine. 2000;  79 250-260
  CrossrefPubMedGoogle Scholar
• 30 Shah A K. Cyclosporine A neurotoxicity among bone marrow transplant recipients.  Clin Neuropharmacol. 1999;  22 67-73
  CrossrefPubMedGoogle Scholar
• 31 Reece D E, Frei-Lahr D A, Shepherd J D et al.. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin.  Bone Marrow Transplant. 1991;  8 393-401
  PubMedGoogle Scholar
• 32 Hinchey J, Chaves C, Appignani B et al.. A reversible posterior leukoencephalopathy syndrome.  N Engl J Med. 1996;  334 494-500
  CrossrefPubMedGoogle Scholar
• 33 Atkinson K, Biggs J, Darveniza P, Boland J, Concannon A, Dodds A. Cyclosporine-associated central nervous system toxicity after allogeneic bone marrow transplantation.  Transplantation. 1984;  38 34-37
  CrossrefPubMedGoogle Scholar
• 34 Bartynski W S, Zeigler Z, Spearmen M P, Lin L, Shadduck R K, Lister J. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity.  AJNR Am J Neuroradiol. 2001;  22 1901-1914
  PubMedGoogle Scholar
• 35 Casey S O, Sampaio R C, Michel E, Truwit C L. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.  AJNR Am J Neuroradiol. 2000;  21 1199-1206
  PubMedGoogle Scholar
• 36 Furukawa M, Terae S, Chu B C, Kaneko K, Kamada H, Miyasaka K. MRI in seven cases of tacrolimus (FK-506) encephalopathy: utility of FLAIR and diffusion-weighted imaging.  Neuroradiology. 2001;  43 615-621
  CrossrefPubMedGoogle Scholar
• 37 Steg R E, Garcia E G. Complex visual hallucinations and cyclosporine neurotoxicity.  Neurology. 1991;  41 1156
  PubMedGoogle Scholar
• 38 Balmaceda C M, Walker R W, Castro-Malaspina H, Dalmau J. Reversal of amphotericin-B-related encephalopathy.  Neurology. 1994;  44 1183-1184
  PubMedGoogle Scholar
• 39 Miyao S, Takano A, Teramoto J, Fujitake S, Hashizume Y. Oculomotor nerve palsy due to intraneural hemorrhage in idiopathic thrombocytopenic purpura: a case report.  Eur Neurol. 1993;  33 20-22
  CrossrefPubMedGoogle Scholar
• 40 Edelson R N, Chernik N L, Posner J B. Spinal subdural hematomas complicating lumbar puncture.  Arch Neurol. 1974;  31 134-137
  CrossrefPubMedGoogle Scholar
• 41 Wen P Y, Alyea E P, Simon D, Herbst R S, Soiffer R J, Antin J H. Guillain-Barré syndrome following allogeneic bone marrow transplantation.  Neurology. 1997;  49 1711-1714
  PubMedGoogle Scholar
• 42 Martino R, Bretagne S, Rovira M et al.. Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Disease Working Party of the European Group for Blood and Marrow Transplantation.  Bone Marrow Transplant. 2000;  25 1111-1113
  CrossrefPubMedGoogle Scholar
• 43 Chandrasekar P H, Momin F. and the Bone . Marrow Transplant Team. Disseminated toxoplasmosis in marrow transplant recipients: a report of three cases and review of the literature.  Bone Marrow Transplant. 1997;  19 685-689
  CrossrefPubMedGoogle Scholar
• 44 Maschke M, Dietrich U, Prumbaum M et al.. Opportunistic CNS infections after bone marrow transplantation.  Bone Marrow Transplant. 1999;  23 1167-1176
  CrossrefPubMedGoogle Scholar
• 45 Davis D, Henslee P J, Markesbery W R. Fatal adenovirus meningoencephalitis in a bone marrow transplant patient.  Ann Neurol. 1988;  23 385-389
  CrossrefPubMedGoogle Scholar
• 46 Conti D J, Rubin R H. Infection of the central nervous system in organ transplant recipients.  Neurol Clin. 1988;  6 241-260
  PubMedGoogle Scholar
• 47 Cordonnier C, Feuilhade F, Vernant J P, Marsault C, Rodet M, Rochant H. Cytomegalovirus encephalitis occurring after bone marrow transplantation.  Scand J Haematol. 1983;  31 248-252
  CrossrefPubMedGoogle Scholar
• 48 Koc Y, Miller K B, Schenkein D P et al.. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome.  Biol Blood Marrow Transplant. 2000;  6 44-49
  CrossrefPubMedGoogle Scholar
• 49 Mookerjee B P, Vogelsang G. Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir.  Bone Marrow Transplant. 1997;  20 905-906
  CrossrefPubMedGoogle Scholar
• 50 Wainwright M S, Martin P L, Morse R P et al.. Human herpesvirus 6 limbic encephalitis after stem cell transplantation.  Ann Neurol. 2001;  50 612-619
  CrossrefPubMedGoogle Scholar
• 51 Guppy K H, Thomas C, Thomas K, Anderson D. Cerebral fungal infections in the immunocompromised host: a literature review and a new pathogen-Chaetomium atrobrunneum: case report.  Neurosurgery. 1998;  43 1463-1469
  CrossrefPubMedGoogle Scholar
• 52 Hagensee M E, Bauwens J E, Kjos B, Bowden R A. Brain abscess following marrow transplantation: Experience at the Fred Hutchinson Cancer Research Center, 1984-1992.  Clin Infect Dis. 1994;  19 402-408
  CrossrefPubMedGoogle Scholar
• 53 Coppo P, Laporte J Ph, Aoudjhane M et al.. Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5).  Bone Marrow Transplant. 1999;  23 401-403
  CrossrefPubMedGoogle Scholar
• 54 Re D, Bamborschke S, Feiden W et al.. Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy.  Bone Marrow Transplant. 1999;  23 295-298
  CrossrefPubMedGoogle Scholar
• 55 Reyes M G, Noronha P, Thomas W, Heredia R. Myositis of chronic graft versus host disease.  Neurology. 1983;  33 1222-1224
  PubMedGoogle Scholar
• 56 Grau J M, Casademont J, Monforte R et al.. Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations.  Bone Marrow Transplant. 1990;  5 435-437
  PubMedGoogle Scholar
• 57 Amato A A, Barohn R J, Sahenk Z, Tutschka P J, Mendell J R. Polyneuropathy complicating bone marrow and solid organ transplantation.  Neurology. 1993;  43 1513-1518
  PubMedGoogle Scholar
• 58 Iwasaki Y, Sako K, Ohara Y et al.. Subacute panencephalitis associated with chronic graft-versus-host disease.  Acta Neuropathol (Berl). 1993;  85 566-572
  PubMedGoogle Scholar
• 59 Padovan C S, Bise K, Hahn J et al.. Angiitis of the central nervous system after allogeneic bone marrow transplantation.  Stroke. 1999;  30 1651-1656
  CrossrefPubMedGoogle Scholar
• 60 Padovan C S, Yousry T A, Schleuning M, Holler E, Kolb H J, Straube A. Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation.  Ann Neurol. 1998;  43 627-633
  CrossrefPubMedGoogle Scholar
• 61 Ma M, Barnes G, Pulliam J, Jezek D, Baumann R J, Berger J R. CNS angiitis in graft vs host disease.  Neurology. 2002;  59 1994-1997
  PubMedGoogle Scholar
• 62 Sostak P, Padovan C S, Yousry T A, Ledderose G, Kolb H J, Straube A. Prospective evaluation of neurological complications after allogenic bone marrow transplantation.  Neurology. 2003;  60 842-848
  PubMedGoogle Scholar
• 63 Cohen J I. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency.  Medicine. 1991;  70 137-160
  CrossrefPubMedGoogle Scholar
• 64 Curtis R E, Rowlings P A, Deeg J et al.. Solid cancers after bone marrow transplantation.  N Engl J Med. 1997;  336 897-904
  CrossrefPubMedGoogle Scholar

Francesc GrausM.D. 

Servei de Neurologia, Hospital Clínic

Villarroel 170

Barcelona 08036, Spain